Table 5c.
Age |
|||
---|---|---|---|
≤ 60 | > 60 | ||
Tumor Site | Oral cavity/oropharynx | 15/48 (31%) | 16/26 (62%) |
Larynx/hypopharynx | 25/54 (46%) | 15/26 (58%) | |
T Stage | T1/T2 | 10/35 (29%) | 6/9 (67%) |
T3/T4 | 30/67 (45%) | 25/43 (58%) |
Age |
|||
---|---|---|---|
≤ 60 | > 60 | ||
Tumor Site | Oral cavity/oropharynx | 15/48 (31%) | 16/26 (62%) |
Larynx/hypopharynx | 25/54 (46%) | 15/26 (58%) | |
T Stage | T1/T2 | 10/35 (29%) | 6/9 (67%) |
T3/T4 | 30/67 (45%) | 25/43 (58%) |